CME Grant Disclosure and Transparency: Company Reports 2009 and 1st Qtr 2010

We have compiled  a chart of companies that disclose their educational grant payments for  2009 and 2010.

In 2009 several new companies reported CME grants and donations including Amilyn, Sanofi Aventis and Shire.    In addition several J&J companies have added grant disclosure.

From reviewing the reports Glaxo Smith Kline took a six month break (Q4 09 and Q1 10) from awarding continuing medical educational grants.  Their plan is to fund projects in Q2 and Q3 2010. 

Company	2010	2009	2008
Abbott		Q1	Q3
		Q2	Q4
		Q3
		Q4
Amilyn		Q1
		Q2
		Q3
		Q4
Amilyn Lilly Grant Office		Q1
(Also listed in Lilly Report)		Q2
		Q3
		Q4
Amgen	Q1	Q1	Q1
		Q2	Q2
		Q3	Q3
		Q4	Q4
Astra Zeneca		1st ½ of 2009	1st ½ of 2008
		2nd ½ of 2009	2nd ½ of 2008
Glaxo Smith Kline	Q1	Full Year
Genentech	Q1
Johnson and Johnson Companies
Biosense Webster		Full Year
Centocor Ortho Biotech		Full Year
Cordis		Full Year
Depuy
Depuy Mitek		Full Year
Depuy Orthopedics		Full Year
Depuy Spine		Full Year
Codman and Shurtleff		Full Year
Ethicon		Full Year
Ethicon Endo Surgery		Full Year
Jansen		Full Year
Lifescan		Full Year
McNeil Pediatrics		Full Year
Ortho McNeil		Full Year
Ortho McNeil Neurologics		Full Year
Ortho Women’s Health and Urology		Full Year
PriCara		Full Year
Scios		Full Year
Tibotech		Full Year
Therakos		Full Year
Eli Lilly	Q1	Full Year
Merck		Q1	Q3
		Q2	Q4
		Q3
		Q4
Pfizer	Q1	Q1	Q1
		Q2	Q2
		Q3	Q3
		Q4	Q4
Sanofi Aventis	Q1	Q2
		Q3
		Q4
Shire	Q1	Q1
		Q2
		Q3
		Q4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

If your company is posting their grants and would like to be included in this report, please let us know so we can add them.

This shows a commitment by companies to support the continuing medical education of health professionals.    Companies are also committed to ethical transparency and disclosing educational grant payments.

It is in the best interest of patients for physicians to be as well informed on the latest science.    In the end we will all benefit from advances in diagnostics and treatments discussed in these courses.